INTRODUCTION
The endothelial cell barrier function is regulated by VE-cadherin-containing adherens junctions in addition to tight junctions 1 . VE-cadherin is involved in maintaining the integrity of endothelial cell junctions by preventing the disassembly of the endothelial barrier and regulating the movement of macromolecules through the endothelium [1] [2] [3] . However, upon VEGF stimulation, these normal endothelial cell junctions are re-organized to allow the extravasation of cellular factors 4 . This involves the disruption of VE-cadherin at the adherens junction 2,4,5 and internalization of VE-cadherin from the cell surface 6 . VEGF stimulation leads to the induction of Rac1 activity 7, 8 and its downstream effector, p21 activated kinase (PAK1) 8 . Additionally, Rac1
has also been shown to regulate VE-cadherin phosphorylation through the generation of reactive oxygen species (ROS) 9,10 .
Kaposi's sarcoma (KS) is a multifocal vascular tumor of mixed cellular composition. KS lesions are comprised of a mixed population of cells including spindle-shaped endothelial cells and infiltrating leukocytes 11, 12 . KS is the most common neoplasm in patients with acquired immunodeficiency syndrome (AIDS). Areas that have the highest HIV burden, such as SubSaharan Africa, also have the highest rate of Kaposi's sarcoma (KS). Kaposi's sarcomaassociated herpesvirus (KSHV) is the etiological agent found in all epidemiological forms of KS 13 , and viral genomic DNA is present in AIDS-associated KS, as well as HIV-negative classic and transplant-associated KS 13, 14 . Since the discovery of the virus in KS, KSHV has also been consistently identified in primary effusion lymphoma (PEL) and some forms of multicentric Castleman's disease (MCD) [15] [16] [17] . KSHV infection of the endothelial cells in the KS lesions is thought to drive proliferation of the tumor.
Three histological features of KS lesions are cellular proliferation, inflammation, and angiogenesis and several studies have shown a high level of cytokines and chemokines within KS lesions [18] [19] [20] [21] . The KS lesion has been shown to express high levels of vascular endothelial growth factor (VEGF) and fibroblast growth factor (bFGF), which are necessary for the only.
For personal use at UNIV NORTH CAROLINA on September 12, 2011. bloodjournal.hematologylibrary.org From maintenance of the angiogenic lesion 19, 22 . In addition, KS-derived cells constitutively release matrix metalloproteinase 9 23 . KSHV encodes for many proteins and some of these are involved in cell proliferation and the upregulation of angiogenesis. The viral G protein-coupled receptor (vGPCR) is a homolog of human IL-8 receptor that induces expression of mitogenic and angiogenic growth factors including VEGF 24, 25 . vIL6, a homolog of human IL-6 has also been implicated in the development of tumorigenesis and angiogenesis 19 . Our previous studies have
shown that the KSHV K1 protein induces the secretion of VEGF, MMP-9, and also enhances angiogenesis and tumor size in vivo 26, 27 . All three genes are expressed during the viral lytic cycle but vIL6 and K1 are also expressed at low levels during viral latency 26, 28 .
We have previously demonstrated that latent KSHV infection of endothelial cells induces the activation of the pro-survival PI3K/Akt/mTOR pathway 29 . Latent KSHV infection of endothelial cells augmented cell survival and increased the angiogenic potential of endothelial cells even under conditions of stress 29 . Our findings confirmed that latent KSHV infection of endothelial cells activates key pathways involved in promoting cell survival and angiogenesis, thereby contributing to the pathogenesis induced by KSHV in endothelial cells.
Here we report that latent KSHV infection of endothelial cells increases vascular permeability. We demonstrate that latent KSHV-infected endothelial cells display increased Rac1 activity and activation of its downstream modulator, PAK1. KSHV-infected endothelial cells exhibited increased phosphorylation of VE-Cadherin and β-catenin, which likely contribute to the disruption of endothelial cell junctions. Consistent with these biomolecular markers, we found that latent KSHV-infected endothelial cells were more permeable than uninfected endothelial cells and that the KSHV K1 protein can induce Rac1 activation. Knockdown of Rac1 or inhibition of ROS resulted in decreased permeability in the KSHV-infected endothelial cells suggesting that ROS and Rac1 are important mediators of KSHV-driven vascular permeability.
only.
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MATERIALS AND METHODS
Cell Culture. KSHV-infected human umbilical vein endothelial cells (KSHV-HUVEC) were made by infecting immortalized HUVEC with recombinant KSHV virus as previously described 29 .HUVEC and KSHV-HUVEC were cultured in endothelial growth medium (EGM-2, Clonetics), while the KSHV-HUVEC cells were additionally cultured in the presence of 0.5μg/ml puromycin.
Reagents and Antibodies. N-acetyl cysteine was purchased from Sigma. DPI was obtained from Calbiochem. VE-cadherin and p120 catenin antibodies were obtained from Santa Cruz Biotechnology, and the phospho-specific VE-cadherin antibodies were from BIOSOURCE (Camarillo, CA). The antibody against Rac1 was from BD Biosciences and the anti-Rac1-GTP antibody was purchased from Neweast Biosciences. The β -catenin PY654 antibody was purchased from AbCam. Monoclonal antibody anti-phosphotyrosine (clone 4G10) was obtained from Upstate Biotechnology. Anti-PAK1 was obtained from Cell Signaling.
siRNA and adenoviral infections.
siRNAs were purchased from the UNC Nucleic Acid
Core Facility/Sigma-Genosys (Sigma-Aldrich). The following siRNAs were used in this study:
Negative control siRNA (Guide strand 5'-UCACUCGUGCCGCAUUUCCUU-3'), Rac1 siRNA (Guide strand 5'-AAACUCGCUAUGAAAUCACUU-3'). siRNAs were transfected with Lipofectamine RNAiMAX in 1 ml of OPTI MEM (Invitrogen).
Adenoviral Infection were performed with WT and VE-Cadherin mutants. Wild-type VE-cadherin, VE-cadherin Y658F, VE-cadherin Y731F, and VE-cadherin Y658F/Y731F were generated as previously described 30 . Endothelial cells were infected with adenovirus for 48 h prior to harvest.
Dextran Flux Assay. Endothelial cells were grown to confluence for a minimum of 3 days in the top well of a Transwell filter (0.4 µm, 12-mm diameter, Corning). 10 kDa or 40 kDa only.
For personal use at UNIV NORTH CAROLINA on September 12, 2011. bloodjournal.hematologylibrary.org From tetramethylrhodamine dextran (Molecular Probes) was added to the top chamber of the Transwell for a final concentration of 1 mg/ml. After 6 hours, the sample was removed from the bottom compartment and read in a fluorometer (FLUOStar OPTIMA, BMGLabtech, excitation 555 nm, emission 580 nm).
Immunofluorescence and Immunohistochemistry. Cells were grown on collagen-coated coverslips. Cells were fixed for 15 min in 4% formaldehyde, permeabilized in 0.3% Triton X-100 for 10 min, and blocked for 10 min in 5% bovine serum albumin. Immunofluorescence images were taken with a Zeiss axiovert 200M microscope equipped with a Hamamatsu ORCA-ERAG digital camera and Metamorph workstation (Universal Imaging Corp.).
For immunohistochemistry, TIVE tumors from mice were excised, fixed in 10% neutral buffered formalin, paraffin-embedded and 5 µm sections were prepared on slides. Additionally, normal human skin slides were obtained from US Biomax, Inc. and KS tissues slides were obtained from ACSR. Slides were deparaffinized using Histochoice Clearing Agent (Sigma-Aldrich) and rehydrated using graded ethanol, followed by extensive washing with water. Endogenous peroxidase activity was quenched with 3% H 2 O 2 in 10% methanol solution, and antigens were exposed by heating sections for 15 minutes in 1mM ethylenediaminetetraacetic acid (pH 8.0), and cooled to room temperature. Nonspecific antigens were blocked using a blocking buffer were harvested and lysed as described above. 500 µg of cell lysate was used per immunoprecipitation along with 1 µg of anti-Rac1-GTP antibody. The immunoprecipitations were performed at 4C for 14 hours after which the immunoprecipitates were washed and loaded on only.
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PAK1 kinase assay. PAK1 kinase assay was performed as described by Knaus et al. (1995) 32 . Cells were plated in 100 mm dishes. When confluent, cells were washed with PBS twice and harvested. Cells were spun down at 4000 rpm for 10 min. 400 µl of cold lysis buffer (1% NP-40, 50 mM Tris-HCl, pH 8.0 and 150 mM NaCl) was added and the samples were incubated on ice for 30 min. The lysates were sonicated and the samples were spun at 13,500 rpm at 4°C.
The supernatants were harvested and 500 µg of lysate in 500 µl lysis buffer was mixed with 6 µl of anti-PAK1 antibody and incubated at 4°C for 2 hrs. 25 µl of protein A/G plus-agarose (Santa Cruz Biotechnology) were added and samples were nutated at 4°C overnight, washed in lysis For personal use at UNIV NORTH CAROLINA on September 12, 2011. bloodjournal.hematologylibrary.org From buffer three times followed by two washes with kinase buffer (50 mM HEPES, 150 mM NaCl, 5 mM MgCl,10 mM NaF and 1 mM Na 3 VO 4 ). Src kinase assays were performed as per manufacturer's instruction (Src Assay Kit, cat#:17-131, Millipore). 25 μl of the kinase reaction solution was spotted onto P81 filter paper. The filter was washed with 0.75% phosphoric acid five times and once with acetone. The filter was transferred to a vial for counting with a scintillation counter.
Scratch Assay

× 10
5 HUVEC and KSHV-HUVEC were seeded in one well of a 6-well dish. Cells were scratched with a P10 pipette tip 24h later. Cells were imaged at 0h, 6h and 12 hour. The percentage of gap filled with migrated cells at 6h was calculated by measuring the space filled by cells at 6h and normalizing to the gap measured at 0h.
PCR of viral genes
Primer sets used to detect viral gene expression are as follows. For personal use at UNIV NORTH CAROLINA on September 12, 2011. bloodjournal.hematologylibrary.org Transcriptase (Invitrogen). One µl of cDNA sample was subjected to PCR and the products were electrophoresed on an agarose gel.
VEGF quantitation
×10
5 HUVEC and KSHV-HUVEC were seeded in one well of a 6-well dish. Twenty four hours later, cells were washed twice with PBS and 3 mls of 2% FBS media without supplements was added. The supernatants were harvested at 48h and subjected to Luminex profiling using the human 15-plex Luminex kit (Millipore).
RESULTS
Rac1 is activated in latent KSHV-infected endothelial cells.
We had previously reported the generation of KSHV-infected HUVEC using the rKSHV.219 strain of KSHV which expresses green fluorescent protein (GFP) under a CMV promoter and red fluorescent protein (RFP) under the promoter for the viral lytic gene, PAN 33 .
The KSHV-infected cells are highly latent and only express GFP and not RFP (Supplemental Figure 1A) . Additionally, using PCR to detect viral gene expression we can detect expression of both latency associated nuclear antigen (LANA/Orf73) and K1 in the KSHV-HUVEC (Supplemental Figure 1B) . This result is consistent with other reports from Ganem and colleagues that have shown that K1 is transcribed in latent KSHV-infected cells, including tightly latent infected endothelial cells 28 . Although we did not find expression of the lytic gene, RTA (Supplemental Figure 1B) , we cannot rule out the possibility that there is still some lytic gene expression that is below the level of detection of our RT-PCR.
We and others have previously reported that KSHV-infected endothelial cells upregulate VEGF expression and secretion 29, 34 . We found that KSHV-HUVEC cells secrete approximately four times as much VEGF into the supernatant than uninfected HUVEC cells ( Figure 1A ). To determine if latent KSHV infection affects Rac1 activity in endothelial cells, we utilized latent only.
For personal use at UNIV NORTH CAROLINA on September 12, 2011. bloodjournal.hematologylibrary.org From 1 1 KSHV-infected human umbilical vein endothelial cells (KSHV-HUVEC) and uninfected HUVEC which have been previously described 29 . We assessed Rac1 activation using a Rac1-GTP pulldown assay with glutathione S-transferase-p21-binding domain (GST-PBD). The latent KSHV-HUVEC displayed high levels of Rac1 activity compared to uninfected cells ( Figure 1B ).
Similar results were obtained using immunoprecipitation of activated Rac1-GTP ( Figure 1C )
from uninfected and KSHV-infected HUVEC. Src kinase activation is known to lead to the activation of Rac1 35 , hence we performed a Src kinase activity assay in uninfected and latent KSHV-infected endothelial cells. We found that the latent KSHV-infected endothelial cells displayed increased Src kinase activity (Fig. 1D ). Rac1 activation has previously also been shown to correlate with activation of PAK1 6, 36, 37 . Hence, we also analyzed the activity of PAK1
by performing an immunoprecipitation with PAK1 antibody followed by an in vitro kinase assay using myelin binding protein (MBP) as a substrate. We found that PAK1 was more activated in the latent KSHV infected endothelial cells ( Figure 1E ). 
Latent KSHV infection increases VE
Latent KSHV infection affects junctional integrity.
Tyrosine phosphorylation of junctional proteins is indicative of decreased junctional integrity. To further explore junctional integrity during latent KSHV infection, we examined VEcadherin and β -catenin localization ( Figure 4A and B) . As can be seen in the magnified area in Figure 4A , there appears to be interrupted VE-cadherin staining in KSHV-HUVEC compared to uninfected HUVEC. In KSHV infected endothelial cells, VE-cadherin and β-catenin staining was moderately altered, displaying irregular and jagged junctions. Additionally, immunofluorescence only.
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Latent KSHV infection increases endothelial permeability in a Rac1 dependent manner.
To determine if the junctional dysregulation observed in latent KSHV-infected endothelial cells impacts endothelial cell permeability, we used a FITC-dextran Transwell assay. KSHV-HUVEC or uninfected HUVEC were grown to confluence on transwell filters and rhodaminedextran was added. We found that KSHV-infected endothelial cells were much more permeable to 10 kD dextran ( Figure 5A ). An increase in permeability of the KSHV-infected endothelial cells was also observed with 40 kD dextran ( Figure 5B ).
To test if Rac1 contributes to the increase in permeability observed in KSHV-HUVEC, we knocked down Rac1 using siRNA. As shown in Figure 5C , depletion of Rac1 abrogated the permeability of KSHV-HUVEC cells to 10 kd dextran. Since we demonstrated that latent infection with KSHV increases VE-cadherin phosphorylation in a Rac1-dependent manner ( Figure 3A) , we next wanted to determine if VE-cadherin phosphorylation was critical for the ability of KSHV to enhance vascular permeability. Wild-type (WT) VE-cadherin or a double mutant where both tyrosine 658 and 731 had been mutated to phenylalanines (YY/FF) were transfected into the HUVEC and KSHV-HUVEC. We found that KSHV infection increased vascular permeability in endothelial cells expressing WT VE-cadherin ( Figure 5D ). However, expression of the phosphorylation-resistant double mutant of VE-cadherin (YY/FF) reduced the effect of KSHV infection on endothelial cell permeability ( Figure 5D ). Taken together these results demonstrate that latent KSHV infection increases vascular permeability through Rac1-mediated phosphorylation of VE-cadherin.
Defects in cell-cell adhesion junctions can impact the capacity of cells to migrate collectively 41 , and increases in activated Rac1 can increase migratory ability. We investigated whether KSHV infection affected endothelial cell migration by performing a scratch assay.
Briefly, HUVEC and KSHV-HUVEC cells were plated and grown to confluency. The cell only.
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KSHV-induced endothelial permeability requires reactive oxygen species (ROS) production.
We recently demonstrated that Rac1 regulates VE-cadherin tyrosine phosphorylation through the generation of ROS 9, 10 . To test if ROS production contributes to KSHV-induced VEcadherin phosphorylation, we used the free radical scavenger, NAC. We found that treatment with NAC inhibited the KSHV-induced increase in VE-cadherin phosphorylation ( Figure 6A ). To further examine the role of ROS in KSHV-mediated increase in vascular permeability, KSHV-HUVEC and uninfected HUVEC were grown to confluence on Transwell filters and treated with NAC. As expected, NAC abrogated the effect of KSHV infection on endothelial permeability to 10kd dextran ( Figure 6B ). Knockdown of Rac1 also reduced PAK1 kinase activity in latent KSHV-HUVEC and treatment with the ROS scavenger, NAC, dramatically reduced PAK1 activation in these cells ( Figure 6C ). In order to determine whether NADPH oxidase was the main source of ROS responsible for the endothelial permeability, we treated cells with either 0, 0.5 or 2 μM of a NADPH oxidase inhibitor, diphenyleneiodonium (DPI), as previously described 9 . We found that both concentrations of DPI significantly reduced the tyrosine phosphorylation of VE-cadherin ( Figure 6D ) suggesting that NADPH oxidase is the primary source for generation of ROS and induction of vascular permeability in the KSHV infected endothelial cells.
In an effort to determine which viral protein expressed in the latently infected KSHV-HUVEC could activate Rac1, we tested whether the KSHV K1 protein could activate Rac1. The reason for examining K1 specifically was because it has previously been reported that K1 can induce VEGF expression and VEGF-VEGFR signaling in endothelial cells 26, 42 and therefore seemed a likely candidate. Additionally, Supplemental Figure 1B shows that K1 is transcribed in only.
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To determine if K1 was able to activate Rac1, HEK293 cells were transfected with either pcDNA3 vector alone or pcDNA3-K1 and forty eight hours post-transfection, cells were harvested and subjected to immunoprecipitation with anti-Rac1-GTP antibody followed by
Western blotting for Rac1 antibody. In three independent experiments, we found that expression of K1 increased Rac1 activation ( Figure 7A ).
Finally, in order to determine whether activated Rac1 is present in KSHV-infected tumors, we injected nude mice with 1x10 6 TIVE cells 43 which are KSHV-infected endothelial cells (HUVEC) that have been previously reported to form tumors in immunodeficient mice 43 .
Tumors were harvested, sectioned and immunohistochemistry was performed with normal mouse IgG as a control antibody or an anti-Rac1-GTP antibody which specifically detects the activated form of Rac1. As can be seen in Figure 7B , KSHV-infected endothelial cell tumors display high levels of activated Rac1 protein. Additionally, we also stained normal skin (Fig. 7C) and KS tissue sections from two different donors (Fig. 7D) . We found that both KS tumor sections displayed increased amounts of activated Rac1-GTP compared to normal skin.
DISCUSSION
The majority of cells in the KS lesion are latently infected with KSHV but not much is known about the effects of latent KSHV infection on endothelial cell permeability. Studies assessing endothelial cell permeability have only been performed in the context of KSHV lytic infection. These studies showed that lytic infection leads to the degradation of VE-cadherin in endothelial cells 44 and that the KSHV K5 and vGPCR lytic viral proteins may be responsible for this effect 45, 46 . KSHV lytic infection of endothelial cells resulted in the downregulation of VEcadherin protein levels by 4 hours post-infection 44 . Additionally, KSHV K5 was specifically only.
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Since the majority of the KS lesion is comprised of latently infected endothelial cells, we examined Rac1 activation and endothelial cell permeability in the context of viral latency.
We found that similar to lytic infection, latent KSHV infection of endothelial cells also results in the disruption of endothelial cell junctions, albeit through an independent and completely different mechanism. We found that the KSHV K1 is transcribed in the latently infected endothelial cells similar to other reports 26, 28 and now demonstrate that K1 can activate Rac1. It is possible that other latent viral proteins may also contribute to Rac1 activation. Although the total levels of VE-cadherin remained equal in uninfected and latently infected endothelial cells, the tyrosine phosphorylation levels of VE-cadherin in latently infected cells was greatly increased. This suggests that during latent infection, KSHV is activating signal transduction pathways that lead to the tyrosine phosphorylation of VE-cadherin resulting in endothelial cell disruption. We found an increase in Src kinase activity and activated Rac1 in KSHV-infected endothelial cells compared to uninfected cells. PAK1, a downstream target of activated Rac1, was also activated in the KSHV-infected cells compared to the uninfected cells. These data are corroborated by the fact that both KSHV-infected endothelial cell tumors generated in nude mice, as well as KS tumors, display high levels of Rac1-GTP.
We found that activated Rac1 was required for the increased phosphorylation of VEcadherin and β-catenin in KSHV-infected cells as well as the increased permeability of the KSHV-infected endothelial cells because Rac1 knockdown reduced the phosphorylation of both VE-cadherin and β-catenin and also reduced cell permeability. The activation of Src and Rac1
have been shown to result in increased ROS production 9, 10 . Treatment with the ROS inhibitor, NAC, reduced VE-cadherin phosphorylation levels and KSHV-induced vascular permeability.
NADPH oxidase is a major source of ROS in endothelial cells 47 and Rac1 is known to regulate only.
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Other laboratories have shown that the KSHV lytic vGPCR protein can affect Rho protein activity 25, 45, 46, 48, 49 and activate VEGF and Rac1 24, 25, 49 . Here we show that KSHV K1 can also activate Rac1. This suggests that both KSHV latent and lytic viral proteins expressed in KS tumors synergize to upregulate Rac1 signaling and increase vascular permeability. The virus needs both lytic and latent genes for its survival and pathogenesis. Without lytic genes, the virus cannot replicate and exert paracrine effects on uninfected cells, and without latent genes the virus cannot persist and establish latency in the infected host. Since KSHV encodes for more than a hundred viral genes and microRNAs combined, it is likely that both lytic and latent gene products are needed for survival of the virus and that these work in synergy.
In summary, we find that under conditions of latent infection, KSHV dramatically upregulates the activity of Rac1 leading to endothelial junction dysregulation and increased vascular permeability. KSHV K1 is expressed in latently infected endothelial cells and can activate Rac1. Human KS tumors display prominent angiogenesis and vascular permeability which is attributed to the ability of the virus to upregulate pro-angiogenic factors. Our findings correlate well with the increased vascular permeability seen in human KS tumor lesions 50 and
suggest that viral infection with KSHV is the key inducer of disrupted endothelial cell junctions.
The increased vascular permeability may result from the increased secretion of VEGF from infected cells and one might speculate that this may allow the virus to attract leucocytes to the site of KSHV infected endothelial cells and help the virus to spread to other cell types e.g. B cells and monocytes.
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